The abstract is read at the publisher; the summary is JClub's.
In RB1-deregulated CRPC-NE models, minor spliceosome (MiS) activity—tracked by U6atac—restricts E2F transcriptional programs, with U6atac depletion causing E2F mis-splicing and E2F1-MIRI biomarker translation.
- Why it matters: RB1 loss yields constitutive E2F activation and CDK inhibitor resistance, leaving few post-transcriptional levers to restrain E2F-driven lineage plasticity in CRPC-NE.
- What they did: An in vivo CRISPR screen nominated MiS as the strongest dependency, and U6atac correlated with E2F programs in a clinical CRPC cohort; U6atac depletion was tested for splicing, arrest, and E2F1-MIRI translation.
- The result: MiS inhibition mis-spliced typical E2Fs, induced cell-cycle arrest, and produced E2F1-MIRI as a pharmacodynamic readout; combining E2F activator depletion further promoted neuroendocrine specification and shifted NE identity toward DLL3.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.